We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Genus Plc | LSE:GNS | London | Ordinary Share | GB0002074580 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
84.00 | 4.71% | 1,868.00 | 1,854.00 | 1,860.00 | 1,872.00 | 1,776.00 | 1,776.00 | 80,575 | 16:35:03 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 689.7M | 33.3M | 0.5043 | 36.84 | 1.23B |
TIDMGNS
RNS Number : 7856R
Genus PLC
04 March 2019
4 March 2019
Genus plc
Director/PDMR Shareholding
Genus plc (LSE: GNS) announces that, further to the vesting of contingent rights over ordinary shares in Genus on 5 January 2019 under an individual restricted stock award agreement, Dr. Nate Zwald, a member of the Genus Executive Leadership Team, sold ordinary shares in Genus on 1 March 2019, on the London Stock Exchange to offset income tax and social security liabilities due on the exercise, and retained the balance of ordinary shares.
The below notification made in accordance with the requirements of the EU Market Abuse Regulation, gives further detail of the number of contingent rights exercised and ordinary shares sold.
For further information please contact:
Genus:
Vaughn Walton, Interim Deputy Company Secretary Tel: +44 (0)1256 347100
Table A - GELT Restricted Stock Award Exercise
1. Details of the person discharging managerial responsibilities / person closely associated a. Name Dr. Nate Zwald ============================== ====================================================== 2. Reason for the notification ====================================================================================== a. Position/status Chief Operating Officer, Genus ABS Dairy ============================== ====================================================== b. Initial notification Initial notification /Amendment ============================== ====================================================== 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ====================================================================================== a. Name Genus plc ============================== ====================================================== b. LEI 54930022EOITNKSIGH56 ============================== ====================================================== 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted ====================================================================================== a. Description of Ordinary shares of 10p each the Financial instrument, type of instrument GB0002074580 Identification code ============================== ====================================================== b. Nature of the Acquisition of shares following exercise of transaction 3,612 contingent rights under an individual restricted stock award agreement. ============================== ====================================================== c. Price(s) and volume(s) Price(s) Volume(s) 0p 3,612 ---------- ============================== ====================================================== d. Aggregated information Average price(s) Total volume(s) * Aggregated volume 0p 3,612 ---------------- * Price ============================== ====================================================== e. Date of the transaction 2019-03-01 ============================== ====================================================== f. Place of the transaction Outside a trading venue. ============================== ====================================================== Details of the transaction(s): section to be repeated for (i) 4. each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted ====================================================================================== a. Description of Ordinary shares of 10p each a. the Financial instrument, type of instrument GB0002074580 Identification code ============================== ====================================================== b. Nature of the Sale of 1,293 shares arising from the exercise b. transaction of contingent rights under an individual restricted stock award agreement, to offset income tax and social security liabilities due on the exercise. ============================== ====================================================== c. Price(s) and volume(s) Price(s) Volume(s) c. 2,198.0404p 1,293 ---------- ============================== ====================================================== d. Aggregated information Average price(s) Total volume(s) d. * Aggregated volume 2,198.0404p 1,293 ---------------- * Price ============================== ====================================================== e. Date of the transaction 2019-03-01 ============================== ====================================================== f. Place of the transaction London Stock Exchange, Main Market (XLON) ============================== ======================================================
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
DSHUSAVRKRAORAR
(END) Dow Jones Newswires
March 04, 2019 10:11 ET (15:11 GMT)
1 Year Genus Chart |
1 Month Genus Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions